Literature DB >> 16295192

Reducing the risk of deep wound infection in primary joint arthroplasty with antibiotic bone cement.

Jon E Block, Harrison A Stubbs.   

Abstract

Despite significant advances in intraoperative antimicrobial procedures, deep wound infection remains the most serious complication associated with primary, cemented total joint arthroplasty. A systematic review was conducted to evaluate studies of antibiotic bone cement prophylaxis for reducing the risk of deep wound infection. The literature included 22 articles providing estimates of the prophylactic effectiveness of antibiotic cement. In reducing deep wound infection, antibiotic cement was consistently superior to plain cement, similar to systematic antiobiotics, and independent and additive in effect when combined with other prophylactic measures. Randomized controlled trials in particular had important methodological limitations. However, the collective results nearly unanimously favored prophylactic use of antibiotic cement in primary arthoplasty procedures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16295192     DOI: 10.3928/0147-7447-20051101-13

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  9 in total

1.  Staphylococcal persistence due to biofilm formation in synovial fluid containing prophylactic cefazolin.

Authors:  Sana S Dastgheyb; Sommer Hammoud; Constantinos Ketonis; Andrew Yongkun Liu; Keith Fitzgerald; Javad Parvizi; James Purtill; Michael Ciccotti; Irving M Shapiro; Michael Otto; Noreen J Hickok
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

Review 2.  The Use of Antibiotic Impregnated Cement Spacers in the Treatment of Infected Total Joint Replacement: Challenges and Achievements.

Authors:  Omid Shahpari; Alireza Mousavian; Nafise Elahpour; Michael-Alexander Malahias; Mohammad H Ebrahimzadeh; Ali Moradi
Journal:  Arch Bone Jt Surg       Date:  2020-01

3.  Increasing risk of revision due to deep infection after hip arthroplasty.

Authors:  Håvard Dale; Geir Hallan; Geir Hallan; Birgitte Espehaug; Leif I Havelin; Lars B Engesaeter
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

4.  In-vitro analysis of the effect of gentamicin and polyhexanide on bone tissue.

Authors:  Hans-Jürgen Kock; Dirk Ernst; Frank Jethon; Werner Fabry
Journal:  Int Orthop       Date:  2013-01-26       Impact factor: 3.075

Review 5.  Control strategies to prevent total hip replacement-related infections: a systematic review and mixed treatment comparison.

Authors:  Henry Zheng; Adrian G Barnett; Katharina Merollini; Alex Sutton; Nicola Cooper; Tony Berendt; Jennie Wilson; Nicholas Graves
Journal:  BMJ Open       Date:  2014-03-06       Impact factor: 2.692

6.  DOES TOPICAL USE OF GENTAMICIN REDUCE THE INFECTION RATE IN PRIMARY TOTAL HIP ARTHROPLASTY?

Authors:  Caio Luiz de Toledo Oliveira; Felipe Abrahão Elias; André Dos Santos Ribacionka; Celso Hermínio Ferraz Picado; Flávio Luís Garcia
Journal:  Acta Ortop Bras       Date:  2019 Jul-Aug       Impact factor: 0.513

7.  Intestinal methicillin-resistant Staphylococcus aureus causes prosthetic infection via 'Trojan Horse' mechanism: Evidence from a rat model.

Authors:  Hongyi Zhu; Hanqiang Jin; Changqing Zhang; Ting Yuan
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

8.  Gut permeability may be associated with periprosthetic joint infection after total hip and knee arthroplasty.

Authors:  Emanuele Chisari; Jeongeun Cho; Marjan Wouthuyzen-Bakker; Javad Parvizi
Journal:  Sci Rep       Date:  2022-09-05       Impact factor: 4.996

9.  Evidence base and practice variation in acute care processes for knee and hip arthroplasty surgeries.

Authors:  Marcel Mayer; Justine Naylor; Ian Harris; Helen Badge; Sam Adie; Kathryn Mills; Joseph Descallar
Journal:  PLoS One       Date:  2017-07-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.